- Home
- SUI vs ICLR Comparison
SUI vs ICLR Comparison
Compare SUI & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUI
- ICLR
- Stock Information
- Founded
- SUI 1975
- ICLR 1990
- Country
- SUI United States
- ICLR Ireland
- Employees
- SUI N/A
- ICLR N/A
- Industry
- SUI Real Estate Investment Trusts
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- SUI Real Estate
- ICLR Health Care
- Exchange
- SUI Nasdaq
- ICLR Nasdaq
- Market Cap
- SUI 17.1B
- ICLR 15.3B
- IPO Year
- SUI 1993
- ICLR 1998
- Fundamental
- Price
- SUI $130.24
- ICLR $179.07
- Analyst Decision
- SUI Buy
- ICLR Buy
- Analyst Count
- SUI 10
- ICLR 12
- Target Price
- SUI $136.60
- ICLR $269.00
- AVG Volume (30 Days)
- SUI 846.0K
- ICLR 933.3K
- Earning Date
- SUI 04-28-2025
- ICLR 04-23-2025
- Dividend Yield
- SUI 2.90%
- ICLR N/A
- EPS Growth
- SUI N/A
- ICLR 28.78
- EPS
- SUI 0.71
- ICLR 9.53
- Revenue
- SUI $3,190,400,000.00
- ICLR $8,281,675,999.00
- Revenue This Year
- SUI N/A
- ICLR $2.89
- Revenue Next Year
- SUI $2.50
- ICLR $5.53
- P/E Ratio
- SUI $183.46
- ICLR $18.90
- Revenue Growth
- SUI 0.81
- ICLR 1.99
- 52 Week Low
- SUI $110.98
- ICLR $174.93
- 52 Week High
- SUI $147.83
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- SUI 50.68
- ICLR 39.79
- Support Level
- SUI $127.01
- ICLR $176.03
- Resistance Level
- SUI $131.47
- ICLR $188.05
- Average True Range (ATR)
- SUI 3.07
- ICLR 5.94
- MACD
- SUI -0.37
- ICLR 0.02
- Stochastic Oscillator
- SUI 61.45
- ICLR 31.25
About SUI Sun Communities Inc.
Sun Communities is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company currently owns a portfolio of 666 properties, which includes 350 manufactured housing communities, 179 residential vehicle communities, and 137 marina properties. Sun targets owning properties that are desirable as second homes or vacation properties with nearly 50% of the portfolio located in either Florida or Michigan near major bodies of water.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.